The international consortium on the Ehlers-Danlos syndromes.

Abstract excerpt

Since 1998, two developments have led to concerns that the EDS nosology needs to be substantially revised. The first development was the clinical and molecular characterization of several new EDS variants, which substantially broadened the molecular basis underlying EDS. The second was the growing concern, in the absence of genetic diagnosis, that the hypermobile type of EDS had an expanded phenotype, may be...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Disease Management
• Share to Ehlers-Danlos Syndrome